Free Float 96,91 %
Shares Float 99,96 M
Shares Outstanding 103,15 M
Optimind Pharma Corp.
Share · CA68405U1012 (XCNQ)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Optimind Pharma Corp.
No Price
Share Float & Liquidity
Company Profile for Optimind Pharma Corp. Share
Optimind Pharma Corp. operates as a pharmaceutical company in Canada. The company offers psychedelic therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also operates a clinic that provides medical cannabis and other alternative treatments for various medical ailments, including ketamine-enhanced psychotherapy. The company is headquartered in Toronto, Canada.
Company Data
Name Optimind Pharma Corp.
Company Optimind Pharma Corp.
Website
https://optimindpharma.com
Primary Exchange 
CSE LISTED
CSE LISTED
ISIN CA68405U1012
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO David Goodman
Country Canada
Currency CAD
Employees -
Address TD Centre, North Tower, M5K 1G8 Toronto
IPO Date 2022-08-04
Ticker Symbols
| Name | Symbol |
|---|---|
| CSE LISTED | OMND.CN |
More Shares
Investors who hold Optimind Pharma Corp. also have the following shares in their portfolio:
